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Autoimmune diseasesParaneoplastic myelitis is a rare inﬂammatory disorder most frequently associated with solid tumors or
lymphoproliferative disorders. Patients often harbor onconeuronal antibodies and their prognosis is usually
poor. Here we report a 42-year old woman with longitudinally extensive transverse myelitis and aquaporin-4
(AQP4) antibodies that led to the diagnosis of ovarian teratoma. After tumor removal and immune therapy
(including corticosteroids, plasma exchange, intravenous immunoglobulins and rituximab) the patient
progressively improved achieving complete recovery. Histological study of the teratoma demonstrated
neural tissue containing AQP4 expressing cells and intense inﬂammatory inﬁltrates, providing evidence
for a possible paraneoplastic link between both disorders.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Paraneoplastic myelitis is a rare complication of systemic cancer
with poor prognosis. Most frequently associated neoplasms are
solid tumors (breast, lung) and lymphoproliferative disorders. Clini-
cal, radiological and pathological characteristics of paraneoplastic
myelitis are diverse, and may include transverse inﬂammatory
myelitis and necrotizing myelopathy (Darnell and Posner, 2011;
Flanagan et al., 2011). Well-characterized onconeuronal antibodies
assist in conﬁrming the diagnosis. Anti-aquaporin-4 (AQP4) anti-
bodies are detected in patients with neuromyelitis optica (NMO), a
non-paraneoplastic relapsing inﬂammatory disorder affecting the
spinal cord, optic nerves and sometimes the brain (Lennon et al.,
2005). Of interest, a few patients with NMO-spectrum disorder
with anti-AQP4 antibodies and systemic cancer have recently been
reported (Mueller et al., 2008; Pittock and Lennon, 2008; Armağan
et al., 2012). Here we report a patient with AQP4 antibody positive
longitudinally extensive transverse myelitis (LETM) revealing ovari-
an teratoma. The teratoma expressed the AQP4 antigen, providing a
possible paraneoplastic link between both diseases.ospital Universitari i Politècnic
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rights reserved.
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A 42 year-old female presented to the emergency roomwith urinary
retention. Transvaginal ultrasound demonstrated a right ovarian tumor
which was conﬁrmed on CT and demonstrated a heterogeneous cystic
tumor with fat attenuation. Two days later a right adnexectomy was
performed. Over the following 48 h, the patient developed severe weak-
ness in both legs. A neurology consultation was undertaken. She took no
medications and smoked 20 cigarettes daily until the age of 34. At the age
of 12 she had a one-week episode of cheek paresthesia and blurred
vision in one eye that improved spontaneously. She has a daughter
diagnosed with rheumatoid arthritis. There were no recent symptoms
of infection or vaccinations. Three weeks before admission she started
noticing hiccups, nausea and vomiting, followed by burning pain with
paresthesia in the upper chest, and problems with micturition that
eventually led to urinary retention. Examination revealed normal
cranial nerves. Strength, tone and reﬂexes were normal in the upper ex-
tremities. Both legs were severely paretic (2/5 Medical Research Council
Scale), with ﬂaccid tone and absent deep tendon reﬂexes. Cutaneoplantar
responses were absent. There was a C2 sensory level for pain and light
touch. Vibration and joint position sensations were normally perceived.
The rest of the general and neurological examination was unremarkable.
Spinal magnetic resonance imaging (MRI) is shown in Fig. 1. Brain MRI
was unremarkable. Visual evoked potentials were normal. Routine
laboratory investigations were unrevealing. Autoimmunity serologicalnsverse myelitis with AQP4 antibodies revealing ovarian teratoma, J.
Fig. 1. Spinal cord magnetic resonance imaging of the patient: T2-weighted (A) and short T1 inversion recovery (STIR) (B) MRIs, showing abnormal predominantly central
hyperintense signal extending from the lower brainstem to the conus medullaris; on T1-weighted MRI with gadolinium (C) the lesion is hypointense and shows patchy
non-symmetric areas of mild contrast enhancement.
2 M. Frasquet et al. / Journal of Neuroimmunology xxx (2013) xxx–xxxtests were negative, including anti-thyroid, anti-nuclear and
anti-neutrophil cytoplasm antibodies, and serum immunoﬁxation.
Serologies for the following viruses were negative: CMV, EBV, VZV,
HSV, HCV, HIV, HTLV 1 and 2. There was a positive HBV serology
indicative of past infection (positive anti-HBs and anti-HBc antibodies,
negative HBsAg). Treponema pallidum (TPHA and RPR) serology was
negative. Alpha-fetoprotein levels were within normal limits. Cerebro-
spinal ﬂuid analysis disclosed 260 white blood cells/mL (90% mononu-
clear, 10% polymorphonuclear), mild increase in proteins (80.5 mg/dL)
and normal glucose. CSF contained oligoclonal IgG and IgM bands.
Microbiological CSF studies were negative, including conventional and
mycobacterial cultures, and PCRs for JCV, HSV, VZV, EBV and CMV. CSF
cytology was negative and ﬂow cytometry analysis revealed CD4+ T
lymphocyte predominance, with low percentages of B-lymphocytes
and monocytes. Onconeuronal and NMDA-R antibodies were negative
in serum and CSF. Serum AQP-4 antibodies were found positive at a
titer of 1/40 (indirect immunoﬂuorescence, EUROIMMUN, Medizinische
Labordiagnostika, Lübeck, Germany). The pathological study of the
ovarian tumor showed a mature cystic teratoma with areas of neural
differentiation and AQP-4 expression (Fig. 2). These areas showedFig. 2. (A) Hematoxylin and eosin staining of patient's teratoma section showing cells with
with a monoclonal anti-synaptophysin antibody. Note the reactivity at the surface of neurons
antibody against GFAP (Glial ﬁbrillary acidic protein). (D) Contiguous section incubated wi
the teratoma immunostained with a monoclonal antibody against CD-20 and (F) against CD
matory inﬁltrate cells were also positive for CD4, CD8 and CD3 (not shown).
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and scattered CD138 positive plasma cells/plasmablasts. The patient was
treated with the sequential combination of: 1) a 5-day course of 1 g/day
IV methylprednisolone; 2) seven sessions of plasma exchange; and
3) high dose IV immunoglobulins (0.4 g/kg/day for 5 days). In addition
IV rituximab was administered (1 g 48 h before the 4th plasma
exchange, 1 g 15 days later).With this strategy the patient progressively
improved. After onemonth of physical therapy shewas able towalkwith
bilateral constant aid, and at threemonths shewas fully ambulatory and
able to walk with the occasional use of a cane. Six months later she
received two weekly infusions of 1 g rituximab. At one year follow-up
she had no further relapses. The neurological examination was normal
except for extensor plantar responses, and repeat brain and spinal
MRIs were normal.
3. Discussion
The serum and CSF of patients with paraneoplastic myelitis often
contain well-characterized onconeuronal antibodies such as anti-Hu,
amphiphysin or CRMP5/CV2 (Darnell and Posner, 2011). Symptomsneuronal morphology (arrows). (B) Contiguous section of the tumor immunostained
, marking the synaptic terminals. (C) Section of the tumor incubated with a monoclonal
th monoclonal AQP-4 Ab showing intense immunoreactivity. (E) Contiguous section of
-138, showing inﬁltrates of B lymphocytes and plasma cells/plasmablasts. The inﬂam-
nsverse myelitis with AQP4 antibodies revealing ovarian teratoma, J.
3M. Frasquet et al. / Journal of Neuroimmunology xxx (2013) xxx–xxxdue to the inﬂammation of other areas of the central or peripheral
nervous system are often seen, and the response to therapies is
poor. The tumor expression of the corresponding onconeuronal anti-
gen is a key step in breaking self-tolerance in patients with
paraneoplastic neurological syndromes (PNS) associated with
onconeuronal antibodies. Malignant cells result in aberrant expres-
sion of proteins usually sequestered in the immunoprivileged central
nervous system (CNS) thus leading to paraneoplastic autoimmunity.
In the patient reported here we demonstrated the expression of
AQP4 in areas containing nervous tissue of the ovarian teratoma.
These areas were surrounded by intense inﬂammatory inﬁltrates.
Autoreactive lymphocytes originating in the teratoma could enter
the blood stream, cross the blood–brain barrier and cause the neuro-
logical disease. Alternatively AQP4 antibodies might be produced pe-
ripherally and enter the CNS secondarily (Papadopoulos and
Verkman, 2012). In a recent report of a patient with paraneoplastic
myelitis, breast cancer and AQP4 antibodies, the tumor was also
found to express the AQP4 antigen (Armağan et al., 2012). Because
AQP4 is an antigen whose expression is not restricted to the CNS,
mechanisms leading to paraneoplastic immunity in patients with
AQP4 antibodies probably differ from the classic model proposed
for PNS. Intriguingly, patients with AQP4 antibodies have not been
reported to develop symptoms due to the damage of peripheral
AQP4-expressing organs such as the skeletal muscle or the kidneys.Please cite this article as: Frasquet, M., et al., Longitudinally extensive tra
Neuroimmunol. (2013), http://dx.doi.org/10.1016/j.jneuroim.2013.07.003The incidence of cancer in patients with NMO-spectrum disor-
ders and AQP4 antibodies is unknown, but is likely very low. In a re-
cent series, 5% of such patients had a history of neoplasm (Pittock
and Lennon, 2008). Because only half of these patients developed
cancer within 4 years of the neurological symptom onset, the asso-
ciation between both diseases was likely fortuitous for some of
them. Future studies should address if there are differences in
clinical, immunological and prognostic characteristics between
seropositive NMO patients with and without cancer.
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